TY - JOUR AU - Bazsó, A. AU - Szodoray, P. AU - Shoenfeld, Y. AU - Kiss, Emese TI - Correction: Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review (Clinical Rheumatology, (2024), 10.1007/s10067-024-07123-y) JF - CLINICAL RHEUMATOLOGY J2 - CLIN RHEUMATOL PY - 2024 SN - 0770-3198 DO - 10.1007/s10067-024-07147-4 UR - https://m2.mtmt.hu/api/publication/35428023 ID - 35428023 LA - English DB - MTMT ER - TY - JOUR AU - Erdei, Csilla AU - Heizer, Ágnes AU - Mensch, Károly AU - Szarka, Krisztina AU - Kiss, Emese AU - Márton, Krisztina TI - Oral Mucosal Human Papillomavirus and Epstein-Bar Virus Rates in Patients with Dry Mouth and/or Sjögren's Syndrome in a Hungarian Cohort. JF - ORAL HEALTH & PREVENTIVE DENTISTRY J2 - ORAL HLTH PREV DENT VL - 22 PY - 2024 IS - 1 SP - 443 EP - 452 PG - 10 SN - 1602-1622 DO - 10.3290/j.ohpd.b5718350 UR - https://m2.mtmt.hu/api/publication/35277519 ID - 35277519 AB - To find an association between oral mucosal human papilloma- and/or Epstein-Barr (HPV, EBV) virus infection in patients with dry mouth and/or Sjögren's syndrome (SS) compared to healthy controls and to find connections with salivary gland histopathological alterations.Ninety-two participants were divided into four groups: 1. healthy controls (n = 32); 2. xerostomia (n = 28); 3. hyposalivation (n = 22); and 4. SS groups (n = 10). To detect virus infection brush biopsy was outlined in all groups. Detections of virus-specific sequences were achieved with polymerase chain reaction (PCR). Lip biopsy and histopathological assessment was performed in groups 2, 3 and 4.HPV positivity of oral mucosal cells was shown in group 1: 1 (3.12%); group 2: 3 (10.7%); group 3: 2 (8.26%); and in group 4: 0 of the samples. EBV was present in group 1: 14 (43.7%); group 2: 17 (60.7%); group 3: 6 (27.3%); and in group 4: 5 (50%) of the cases. There was no statistically significant difference between the attributes. Intact salivary gland in 28.2%, chronic sialadenitis in 28.2%, stromal fibrosis in 6.5%, lipomatous atrophy in 8.6%, fibrous atrophy in 6.5% and positive focus score (SS) in 26.1% were found in the subjects. Neither HPV nor EBV infection caused statistically significantly more histological abnormalities.Orofacial mucosal HPV and/or EBV DNA rates did not differ statistically significantly in patients with xerostomia or hyposalivation or SS compared to healthy controls, therefore, it cannot prove the provocative role of these viruses in dry mouth and/or SS. Neither dry mouth nor SS were accompanied by statistically significantly more salivary gland alterations in HPV- and/or EBV-positive subjects; these alterations are frequent in the virus-negative cases too. LA - English DB - MTMT ER - TY - JOUR AU - Bazso, Anna AU - Szodoray, Peter AU - Shoenfeld, Yehuda AU - Kiss, Emese TI - Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review JF - CLINICAL RHEUMATOLOGY J2 - CLIN RHEUMATOL PY - 2024 PG - 18 SN - 0770-3198 DO - 10.1007/s10067-024-07123-y UR - https://m2.mtmt.hu/api/publication/35223434 ID - 35223434 AB - Systemic sclerosis (SSc) is a progressive autoimmune disorder that mainly affects the skin. There are other clinical manifestations as renal, pulmonary, cardiovascular, and gastrointestinal tract involvements. Based on the skin involvement there are two subtypes of SSc, as limited cutaneous SSc (lSSc) which involves the acral part of the body and diffuse cutaneous SSc (dSSc) resulting in significant skin thickening of the body. Despite of the extensive research the pathomechanism is not fully clarified, how Ssc develops, moreover identifying biomarkers to predict the clinical outcome and prognosis still remains challenging. Circulating biomarkers can be crucial to define the diagnosis, to predict the prognosis and monitor the clinical course. However, only some patients are responsive to the therapy in SSc, and there is a need to reach the ideal therapy for any individual to prevent or slow down the progression in early stages of the disease. In this narrative review, our purpose was to summarize the potential biomarkers in Ssc, describe their role in the diagnosis, pathomechanism, clinical course, organ manifestations, as well as the response to the therapy. Biomarkers assessment aids in the evaluation of disease progression, and disease outcome. LA - English DB - MTMT ER - TY - JOUR AU - Tóth, Klaudia AU - Bazsó, Anna AU - Kiss, Emese TI - A felnőttkori Still-betegség patogenezise, klinikai jellemzői és terápiás lehetősége. Rövid áttekintés. JF - MAGYAR REUMATOLÓGIA J2 - MAGYAR REUMATOL VL - 65 PY - 2024 IS - 1 SP - 4 EP - 10 PG - 7 SN - 0139-4495 UR - https://m2.mtmt.hu/api/publication/34889522 ID - 34889522 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Tóth, György AU - Erdei, Csilla AU - Dézsi, Anna AU - Németh, Orsolya AU - Kovács, Alexandra AU - Kiss, Emese AU - Márton, Krisztina TI - A B12-vitamin, vas, folsav, a homocisztein, valamint a D3-vitamin szérumszintek lehetséges összefüggései szájszárazságban és/vagy Sjögren-szindrómában szenvedő hazai betegpopulációban JF - ORVOSI HETILAP J2 - ORV HETIL VL - 165 PY - 2024 IS - 4 SP - 147 EP - 154 PG - 8 SN - 0030-6002 DO - 10.1556/650.2024.32951 UR - https://m2.mtmt.hu/api/publication/34512365 ID - 34512365 N1 - Export Date: 13 May 2024 CODEN: ORHEA LA - Hungarian DB - MTMT ER - TY - JOUR AU - Bazsó, Anna AU - Szabó, Nóra Anna AU - Kiss, Emese TI - Nagyér-vasculitis és spondylitis ankylopoetica társulása JF - MAGYAR REUMATOLÓGIA J2 - MAGYAR REUMATOL VL - 64 PY - 2023 IS - 2 SP - 91 EP - 95 PG - 5 SN - 0139-4495 UR - https://m2.mtmt.hu/api/publication/34889523 ID - 34889523 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Dézsi, Anna AU - Erdei, Csilla AU - Demeter, Tamás AU - Kovács, Alexandra AU - Nagy, Gábor AU - Mensch, Károly AU - Németh, Orsolya AU - Hermann, Péter AU - Tóth, György AU - Füst, Ágnes AU - Kiss, Emese AU - Kőhidai, László AU - Zalatnai, Attila AU - Márton, Krisztina TI - Prevalence of Sjögren’s Syndrome in Patients with Dry Mouth in the Region of Central Hungary JF - ORAL DISEASES J2 - ORAL DIS VL - 29 PY - 2023 IS - 7 SP - 2756 EP - 2764 PG - 9 SN - 1354-523X DO - 10.1111/odi.14264 UR - https://m2.mtmt.hu/api/publication/32847862 ID - 32847862 AB - Abstract Objective One third of the Hungarian population suffers from xerostomia. Since there is no evidence on the actual prevalence of Sjögren?s syndrome (SS) in Hungary, this study aimed to evaluate the same. Materials and Methods Data were collected from the Faculty of Dentistry, Semmelweis University from 2008 to 2015. A diagnosis of SS was established based on the American College of Rheumatology and European League Against Rheumatism criteria. Results Of the 1,076 patients examined with sicca symptoms, 188 patients, had confirmed SS. Primary SS (pSS) was diagnosed in 135 patients, secondary SS (sSS) was confirmed in 53 patients. According to the available statistical records of the public health service of Hungary, there were an average of 16 (0.0014%, 5-26) newly diagnosed SS cases in the entire population and 141 SS patient-practitioner consultations (49-232) per 100,000 inhabitants in the country over the past 10?years (based on the past 10?years: 2011-2020). Conclusion Results revealed that approximately 1/5th?1/6th of patients with sicca symptoms have SS, among whom 72% and 285 have pSS and sSS, respectively. Global Hungarian records simultaneously revealed that the number of both new diagnoses and doctor-SS patient encounters has significantly decreased (by 50%) yearly over the last decade. LA - English DB - MTMT ER - TY - JOUR AU - Kiss, Emese TI - Schmidt Zsuzsanna: A polymyalgia rheumatica új szemlélete, Medicina Könyvkiadó Zrt., Budapest, 2021 [könyvismertetés] JF - MAGYAR REUMATOLÓGIA J2 - MAGYAR REUMATOL VL - 63 PY - 2022 IS - 1 SP - 41 SN - 0139-4495 UR - https://m2.mtmt.hu/api/publication/34889525 ID - 34889525 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Kiss, Emese TI - "A hálózat csapdájában" -avagy 35 éves tevékenységem az immunológia és reumatológia területén JF - MAGYAR REUMATOLÓGIA J2 - MAGYAR REUMATOL VL - 63 PY - 2022 IS - 4 SP - 202 EP - 207 PG - 6 SN - 0139-4495 UR - https://m2.mtmt.hu/api/publication/34889524 ID - 34889524 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Szabó, Nóra Anna AU - Nagy-Vincze, Melinda AU - Griger, Zoltán AU - Mogyoróssy, Sándor AU - Dankó, Katalin AU - Bazsó, Anna AU - Kiss, Emese AU - Szántó, Antónia TI - Idiopathiás inflammatorikus myopathiában alkalmazott rituximab-kezeléssel szerzett tapasztalataink JF - MAGYAR REUMATOLÓGIA J2 - MAGYAR REUMATOL VL - 63 PY - 2022 IS - 2 SP - 85 EP - 89 PG - 5 SN - 0139-4495 UR - https://m2.mtmt.hu/api/publication/33240929 ID - 33240929 LA - Hungarian DB - MTMT ER -